Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues	$ 1,268,447	$ 777,457	$ 3,857,273	$ 2,754,463
Cost of Sales	1,015,843	356,731	2,882,705	1,660,971
Gross Profit	252,604	420,726	974,568	1,093,492
General and Administrative Expenses
Stock compensation and stock issued for services	78,102	2,350	110,852	2,778,550
Impairment expense (Note 1)			46,869
General and administrative	1,126,705	1,697,410	3,627,953	4,347,555
Total General and Administrative Expenses	1,204,807	1,699,760	3,785,674	7,126,105
Loss from Operations	(952,203)	(1,279,034)	(2,811,106)	(6,032,613)
Other Income (Expense)
Other income, net	2,000	141,017	7,878	141,017
Expenses related to convertible notes payable:
Change in fair value of derivative liability		343,000	1,842,000	(3,153,583)
Interest accretion	(25,370)		(49,660)	(766,603)
Interest expense related to Equity Purchase Agreement (Note 11)		(1,805,687)	(2,143,500)	(6,807,587)
Interest expense	(101,766)	(289,585)	(724,129)	(7,173,779)
Total Other Income (Expense)	(125,136)	(1,611,255)	(1,067,411)	(17,760,535)
Net Loss before Income Taxes	(1,077,399)	(2,890,289)	(3,878,517)	(23,793,148)
Income taxes (Note 9)
Net Loss	$ (1,077,339)	$ (2,890,289)	$ (3,878,517)	$ (23,793,148)
Net Basic and Fully Diluted Loss Per Share (in Dollars per share)	$ (0.0636)	$ (0.2048)	$ (0.2325)	$ (2.1424)
Weighted average common shares outstanding
Basic (in Shares)	16,939,276	14,144,032	16,679,847	11,106,013
Fully diluted (in Shares)	16,945,205	16,939,839	16,683,828	17,165,665